Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Micrometastases or isolated tumor cells and the outcome of breast cancer.

de Boer M, van Deurzen CH, van Dijck JA, Borm GF, van Diest PJ, Adang EM, Nortier JW, Rutgers EJ, Seynaeve C, Menke-Pluymers MB, Bult P, Tjan-Heijnen VC.

N Engl J Med. 2009 Aug 13;361(7):653-63. doi: 10.1056/NEJMoa0904832.

2.
3.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
4.

Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.

Chagpar A, Middleton LP, Sahin AA, Meric-Bernstam F, Kuerer HM, Feig BW, Ross MI, Ames FC, Singletary SE, Buchholz TA, Valero V, Hunt KK.

Cancer. 2005 Apr 15;103(8):1581-6. Review.

5.

Prognostic impact of isolated tumor cells and micrometastases in axillary lymph nodes of breast cancer patients.

Tjan-Heijnen VC, Pepels MJ, de Boer M.

Breast Dis. 2010;31(2):107-13. doi: 10.3233/BD-2010-0302. Review.

PMID:
21368373
6.

Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases.

de Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC.

J Natl Cancer Inst. 2010 Mar 17;102(6):410-25. doi: 10.1093/jnci/djq008. Epub 2010 Feb 26. Review.

PMID:
20190185
7.

Significance and management of micrometastases in patients with breast cancer.

Mittendorf EA, Hunt KK.

Expert Rev Anticancer Ther. 2007 Oct;7(10):1451-61. Review.

PMID:
17944569
8.

Prediction of non-SN involvement in patients with SN isolated tumor cells or micrometastases.

Pesce C, Balch C, Jacobs L.

Breast Dis. 2010;31(2):99-106. doi: 10.3233/BD-2010-0301. Review.

PMID:
21368372
9.

Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node.

van Deurzen CH, de Boer M, Monninkhof EM, Bult P, van der Wall E, Tjan-Heijnen VC, van Diest PJ.

J Natl Cancer Inst. 2008 Nov 19;100(22):1574-80. doi: 10.1093/jnci/djn343. Epub 2008 Nov 11. Review.

10.

Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective.

Catzeddu T, Bertelli G, Del Mastro L, Venturini M.

J Surg Oncol. 2004 Mar;85(3):129-32. Review.

PMID:
14991884
11.

[Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].

Meijnen P, Peterse JL, Nieweg OE, Rutgers EJ.

Ned Tijdschr Geneeskd. 2004 Dec 4;148(49):2428-32. Review. Dutch.

PMID:
15626306
12.

The clinical significance of axillary lymph node micrometastases in breast cancer.

Sakorafas GH, Geraghty J, Pavlakis G.

Eur J Surg Oncol. 2004 Oct;30(8):807-16. Review.

PMID:
15336724
13.

Minimal disease in sentinel nodes.

Cserni G.

Pathol Oncol Res. 2008 Jun;14(2):117-21. doi: 10.1007/s12253-008-9052-x. Epub 2008 May 21. Review.

PMID:
18493872
14.

Supplemental Content

Support Center